Works matching IS 25433288 AND DT 2025 AND VI 16 AND IP 2


Results: 12
    1
    2

    Evaluation of Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride SR Tablets 1000 mg in Participants with Inadequately Controlled Type 2 Diabetes Mellitus: A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Clinical Study from India

    Published in:
    Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2025, v. 16, n. 2, p. 182, doi. 10.4103/jod.jod_208_24
    By:
    • Kumthekar, Prashant;
    • Upadhyay, Mihir;
    • Kranti, Vijay;
    • Maheshwari, Sanjiv;
    • Ray, Arindam;
    • Bhattacharya, Raja
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Position of SGLT2i in prediabetes: A systematic review of literature.

    Published in:
    Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2025, v. 16, n. 2, p. 102, doi. 10.4103/jod.jod_238_24
    By:
    • Biswas, Kaushik;
    • Reddy, Vijaya Bhaskar;
    • Seshadri, Krishna;
    • Kapoor, Nitin;
    • Dharmalingam, Mala;
    • Anthuvan, Thamburaj
    Publication type:
    Article
    12